Analyst Joanna Gajuk of Bank of America Securities maintained a Buy rating on Chemed (CHE – Research Report), retaining the price target of $708.00.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Joanna Gajuk has given her Buy rating due to a combination of factors that indicate a positive outlook for Chemed’s Roto-Rooter segment. The significant increase in Google searches for plumbing services in the first quarter of 2025, which rose by 16% quarter-over-quarter and 7% year-over-year, suggests a robust demand that correlates with an expected 3% year-over-year revenue growth for Roto-Rooter. This growth is anticipated to surpass both consensus estimates and previous forecasts.
Additionally, spending data from credit and debit cards shows a 9% year-over-year increase in expenditures on Roto-Rooter services, further supporting the positive revenue outlook. The ability of Roto-Rooter to pass on higher prices to consumers, coupled with the essential nature of its services, provides a solid foundation for future growth. Furthermore, the potential for capital deployment and the strong performance of Chemed’s Vitas segment contribute to the overall positive assessment, justifying the Buy rating.
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue